J Korean Ophthalmol Soc.  2015 Nov;56(11):1759-1766. 10.3341/jkos.2015.56.11.1759.

Change in Visual Acuity Following Trans-Scleral Diode Laser Cyclophotocoagulation in Refractory Glaucoma

Affiliations
  • 1Department of Ophthalmology, Chungnam National University School of Medicine, Daejeon, Korea. kcs61@cnu.ac.kr

Abstract

PURPOSE
To evaluate the effects of trans-scleral diode laser cyclophotocoagulation (TSDLC) on best corrected visual acuity (BCVA) in patients with refractory glaucoma.
METHODS
The medical records of 148 eyes of 148 patients with refractory glaucoma who were followed-up for over 6 months after TSDLC were analyzed retrospectively. Among them, 49 eyes of 49 subjects who had BCVA greater than no light perception (NLP) before TSDLC were classified as Group 1 and the other 99 eyes of 99 patients who had NLP vision were classified as Group 2. The outcomes of TSDLC including change in BCVA following surgery were analyzed for all patients and 49 subjects.
RESULTS
The mean follow-up period in Group 1 was 19.1 +/- 13.5 months and 16.7 +/- 12.7 months in Group 2. The intraocular pressure (IOP) and the number of IOP lowering medications decreased in both groups (both p < 0.001). In all subjects, there was no significant difference between BCVA before surgery and at the last follow-up (2.4 +/- 0.9 log MAR and 2.5 +/- 0.8 log MAR, respectively, p = 0.612). However, in Group 1, BCVA was decreased from 1.4 +/- 1.0 to 1.9 +/- 1.1 log MAR after the TSDLC (p < 0.001). In those patients, visual loss > or = 0.2 log MAR was found in 31 eyes (63.3%) and light perception was lost in 15 eyes (30.6%). After treatment, corneal edema developed in 5 eyes (3.4%), phthisis bulbi and chronic hypotony occurred in 3 eyes each (2%) and iridocydlitis occurred in 2 eyes (1.4%).
CONCLUSIONS
TSDLC in patients with refractory glaucoma showed an efficient reduction in IOP and the number of IOP-lowering medications. However, there was a significant loss in BCVA in many patients and therefore, careful monitoring regarding potential visual loss is necessary when considering TSDLC in glaucoma patients with useful vision.

Keyword

Complication; Refractory glaucoma; Transscleral diode laser cyclophotocoagulation; Visual acuity

MeSH Terms

Corneal Edema
Follow-Up Studies
Glaucoma*
Humans
Intraocular Pressure
Lasers, Semiconductor*
Medical Records
Retrospective Studies
Visual Acuity*

Figure

  • Figure 1. Kaplan-Meier plot showing survival for the loss of vis-ual acuity in group 1 (patients with preoperative BCVA of ‘light perception’ or better). (A) Kaplan-Meier plot showing survival for the loss of 0.1 or more log MAR visual acuity. (B) Kaplan- Meier plot showing survival for the loss of 0.2 or more log MAR visual acuity. (C) Kaplan-Meier plot showing survival for the loss of 0.3 or more log MAR visual acuity. BCVA = best corrected visual acuity.


Reference

References

1. Beckman H, Fuller TA. Carbon dioxide laser scleral dissection and filtering procedure for glaucoma. Am J Ophthalmol. 1979; 88:73–7.
Article
2. Bietti G. Surgical intervention on the ciliary body; new trends for the relief of glaucoma. J Am Med Assoc. 1950; 142:889–97.
3. Alward WLM. Laser cyclophotocoagulation. Weingeist TA, Sneed SR, editors. Laser surgery in ophthalmology: Practical applica-tions. 1st. East Norwalk, Conn: Appleton and Lange;1992. chap. 14.
4. Pastor SA, Singh K, Lee DA. . Cyclophotocoagulation: a re-port by the American Academy of Ophthalmology. Ophthalmology. 2001; 108:2130–8.
Article
5. Assia EI, Hennis HL, Stewart WC. . A comparison of neo-dymium: yttrium aluminum garnet and diode laser transscleral cy-clophotocoagulation and cyclocryotherapy. Invest Ophthalmol Vis Sci. 1991; 32:2774–8.
6. Brancato R, Leoni G, Trabucchi G. . Histopathology of con-tinuous wave neodymium: yttrium aluminum garnet and diode la-ser contact transscleral lesions in rabbit ciliary body. A com-parative study. Invest Ophthalmol Vis Sci. 1991; 32:1586–92.
7. Spencer AF, Vernon SA. “Cyclodiode”: results of a standard protocol. Br J Ophthalmol. 1999; 83:311–6.
Article
8. Kosoko O, Gaasterland DE, Pollack IP, Enger CL. Long-term out-come of initial ciliary ablation with contact diode laser transscleral cyclophotocoagulation for severe glaucoma. The Diode Laser Ciliary Ablation Study Group. Ophthalmology. 1996; 103:1294–302.
9. Francis BA, Kwon J, Fellman R. . Endoscopic ophthalmic sur-gery of the anterior segment. Surv Ophthalmol. 2014; 59:217–31.
Article
10. Panarelli JF, Banitt MR, Sidoti PA. Transscleral diode laser cyclo-photocoagulation after baerveldt glaucoma implant surgery. J Glaucoma. 2014; 23:405–9.
Article
11. Ishida K. Update on results and complications of cyclopho-tocoagulation. Curr Opin Ophthalmol. 2013; 24:102–10.
Article
12. Egbert PR, Fiadoyor S, Budenz DL. . Diode laser transscleral cyclophotocoagulation as a primary surgical treatment for primary open-angle glaucoma. Arch Ophthalmol. 2001; 119:345–50.
Article
13. Wilensky JT, Kammer J. Long-term visual outcome of transscleral laser cyclotherapy in eyes with ambulatory vision. Ophthalmology. 2004; 111:1389–92.
Article
14. Ansari E, Gandhewar J. Long-term efficacy and visual acuity fol-lowing transscleral diode laser photocoagulation in cases of re-fractory and non-refractory glaucoma. Eye (Lond). 2007; 21:936–40.
Article
15. Bloom PA, Tsai JC, Sharma K. . “Cyclodiode”. Trans-scleral diode laser cyclophotocoagulation in the treatment of advanced re-fractory glaucoma. Ophthalmology. 1997; 104:1508–19. discussion 1519-20.
16. Bloom PA, Clement CI, King A. . A comparison between tube surgery, ND:YAG laser and diode laser cyclophotocoagulation in the management of refractory glaucoma. Biomed Res Int 2013;. 2013; 371951.
Article
17. Gupta V, Agarwal HC. Contact trans-scleral diode laser cyclo-photocoagulation treatment for refractory glaucomas in the Indian population. Indian J Ophthalmol. 2000; 48:295–300.
18. Han SK, Park KH. Long-term results of diode laser trans-scleral cyclophotocoagulation in neovascular glaucoma. J Korean Ophthalmol Soc. 1999; 40:523–31.
19. Moon IA, Youn JW. The effect of transscleral diode laser cyclo-photocoagulation in refractory glaucoma. J Korean Ophthalmol Soc. 1999; 40:2252–8.
20. Schuman JS, Puliafito CA, Allingham RR. . Contact trans-scleral continuous wave neodymium:YAG laser cyclophotocoa-gulation. Ophthalmology. 1990; 97:571–80.
Article
21. Schuman JS, Bellows AR, Shingleton BJ. . Contact trans-scleral Nd:YAG laser cyclophotocoagulation. Midterm results. Ophthalmology. 1992; 99:1089–94. discussion 1095.
22. Hampton C, Shields MB, Miller KN, Blasini M. Evaluation of a protocol for transscleral neodymium: YAG cyclophotocoagulation in one hundred patients. Ophthalmology. 1990; 97:910–7.
23. Brindley G, Shields MB. Value and limitations of cyclocryotherapy. Graefes Arch Clin Exp Ophthalmol. 1986; 224:545–8.
Article
24. Dickens CJ, Nguyen N, Mora JS. . Long-term results of non-contact transscleral neodymium:YAG cyclophotocoagulation. Ophthalmology. 1995; 102:1777–81.
25. Eid TE, Katz LJ, Spaeth GL, Augsburger JJ. Tube-shunt surgery versus neodymium:YAG cyclophotocoagulation in the management of neovascular glaucoma. Ophthalmology. 1997; 104:1692–700.
Article
26. Sood S, Beck AD. Cyclophotocoagulation versus sequential tube shunt as a secondary intervention following primary tube shunt failure in pediatric glaucoma. J AAPOS. 2009; 13:379–83.
Article
27. Yildirim N, Yalvac IS, Sahin A. . A comparative study between diode laser cyclophotocoagulation and the Ahmed glaucoma valve implant in neovascular glaucoma: a long-term follow-up. J Glaucoma. 2009; 18:192–6.
28. Ramli N, Htoon HM, Ho CL. . Risk factors for hypotony after transscleral diode cyclophotocoagulation. J Glaucoma. 2012; 21:169–73.
Article
29. Noureddin BN, Zein W, Haddad C. . Diode laser transcleral cy-clophotocoagulation for refractory glaucoma: a 1 year follow-up of patients treated using an aggressive protocol. Eye (Lond). 2006; 20:329–35.
Article
30. Murphy CC, Burnett CA, Spry PG. . A two centre study of the dose-response relation for transscleral diode laser cyclophotocoa-gulation in refractory glaucoma. Br J Ophthalmol. 2003; 87:1252–7.
Article
31. Iliev ME, Gerber S. Long-term outcome of trans-scleral diode laser cyclophotocoagulation in refractory glaucoma. Br J Ophthalmol. 2007; 91:1631–5.
Article
32. Nabili S, Kirkness CM. Trans-scleral diode laser cyclophoto- co-agulation in the treatment of diabetic neovascular glaucoma. Eye (Lond). 2004; 18:352–6.
33. Rotchford AP, Jayasawal R, Madhusudhan S. . Transscleral di-ode laser cycloablation in patients with good vision. Br J Ophthal-mol. 2010; 94:1180–3.
Article
34. Ghosh S, Manvikar S, Ray-Chaudhuri N, Birch M. Efficacy of transscleral diode laser cyclophotocoagulation in patients with good visual acuity. Eur J Ophthalmol. 2014; 24:375–81.
Article
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr